• Login
0 Items
Cannin - Cannabis & Hemp Investment Group
  • Home
  • Get Free Trial
  • Cannabis & Hemp News
  • Investment Resources
    • Featured Companies
    • Company Reports
    • Stock Quotes
    • Directory
  • Contact Us
  • Login
Select Page
Global Cannabis Beverages Market to Reach $2 Billion by 2026

Global Cannabis Beverages Market to Reach $2 Billion by 2026

Aphria, Cannabis in the News, Canopy Growth, CBD Stocks, Cronos Group, Gw Pharmaceuticals, Hemp, Investment Opportunities, marijuana stock, Organigram, Tilray

Global Cannabis Beverages Market to Reach $2 Billion by 2026 — SAN FRANCISCO, Sept. 10, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report...
Developers Strive to Create Innovative Safeguards Against Cannabis Abuse

Developers Strive to Create Innovative Safeguards Against Cannabis Abuse

Cannabis in the News, Cresco, Curaleaf, marijuana stock, Organigram, Research, Safety, Stock Talk, Technology/Innovations

Developers Strive to Create Innovative Safeguards Against Cannabis Abuse — NEW YORK, July 6, 2021 /PRNewswire/ — The cannabis market continues to prove that there is a high demand for such products across the world. The expanding nature of cannabis...
Organigram Stock is Down But is it Out?

Organigram Stock is Down But is it Out?

Cannabis in the News, Investment Opportunities, marijuana stock, Organigram, Stock Talk

Organigram is one of Canada’s leading licensed producers of high-quality recreational and medical cannabis. The company was founded in 2013 as a medical cannabis provider. Now, it is working towards developing an international business partnership to be able to...
Should You Avoid Organigram Stock in 2021?

Should You Avoid Organigram Stock in 2021?

Cannabis in the News, Investment Opportunities, marijuana stock, Organigram, Stock Talk

Should You Avoid Organigram Stock in 2021? The global cannabis market has been growing rapidly over the last few years making it one of the most preferred industries for investors. The Canada-based company Organigram Holdings (NASDAQ: OGI) is a popular licensed...
Organigram (OGI) Reports Q4 2020 Results

Organigram (OGI) Reports Q4 2020 Results

Cannabis in the News, Financial Results, marijuana stock, Organigram, Stock Talk

Organigram (OGI) Reports Q4 2020 Results Organigram (OGI) just reported its Q4 2020 results and here are the key highlights from the earnings call: Q4 2020 net revenue increased 25% to $20.4 million from $16.3 million in Q4 2019 Q4 2020 gross revenue increased 32% to...

Already Registered,
Login below to add a listing

Login

 
 
Forgot Password

Search Cannabis and Hemp Stocks

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Recent Posts

  • Cannin’s Top 5 Cannabis Stocks to Watch Now October 19, 2021
  • Urban-Gro: Is this Cannabis Stock a Strong Buy? October 19, 2021
  • 3 Reasons Why IIPR Will Outperform Marijuana Stocks in 2021 October 19, 2021
  • 3 Volatile Large-Cap Hemp Stocks to Watch for 2021 October 18, 2021
  • 22nd Century: Is this Cannabis Stock a Buy and Hold? October 18, 2021
Top Hemp Stocks to Buy

Cannabis Stock Watchlist

×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
Symbol Last Price % Change

Search for Specific Hemp and Cannabis Stocks

From the Cannin Community

"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"

-Mark H.
Vail, Colorado

https://aphrihelios.com/

CanninPlus with Trading Alerts!

Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.

GET A FREE TRIAL

$99 / month after 7-day trial. Still unsure? Schedule demo at demo@cannin.com or call 720-254-1374

The Best Cannabis Stocks for 2021

  • Cannin Report Q1 2021 Cannin Report Q2 2021 $99.00 $49.00
  • Cannin Report Q1 2021 Cannin Report Q1 2021 $49.00 $29.00
  • Cannin Ad The Cannin Report 2020 $49.00 $19.00
  • Cannin Ad FREE Sample Cannin Report Q1 2020 - Our #1 Stock Pick $9.99 $0.00
  • Cannin Ad The Cannin Report Q4 2019 $99.00 $29.00

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Risk of Prosecution for Marijuana-Related Companies.  If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution.  The Department of Treasury recently issued guidance noting: “ The Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana.  Many states impose and enforce similar prohibitions.  Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”

  • Facebook
  • Twitter
  • Instagram
© 2020 Cannin All Rights Reserved. | Refund | Terms | Privacy | Cannin.com 3000 Lawrence Street #6 Denver, Colorado 80205
CanninBot - Daily Trading Alerts
Terms:
First Week Free, then $39/month. Cancel Anytime.
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above
CanninPlus
Terms:
First Week FREE then $99/month. Cancel Anytime.
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above